Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Simulations Plus (SLP) and University of Connecticut Announce FDA Contract to Accelerate Development of Long-Acting Injectable Products

Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products

October 26, 2021 8:30 AM EDT

Collaboration will combine novel experimental techniques and mechanistic modeling strategies

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries,... More